(Press-News.org) DURHAM, N.C. – A newly discovered hybrid gene appears to play a direct role in some stomach cancers, according to an international team of scientists led by researchers at Duke-NUS Graduate Medical School Singapore.
The hybrid gene is a fusion of two separate genes, and is one of the first described in gastric cancer, which is the most lethal malignancy worldwide after lung cancer. The disease kills an estimated 740,000 people a year, including nearly 11,000 annually in the United States.
The gene discovery may one day give doctors a more effective way to use current therapies, plus help researchers develop new drugs and diagnostic tools for gastric cancer.
"This is an extremely exciting area, as it opens up a potential role for fusion genes in solid cancer diagnostics and treatment, similar to the fundamental role they have played in the blood cancers," said Dr. Patrick Tan, associate professor in the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School Singapore. Tan was principal investigator of the study published in the April 6, 2011, issue of the journal Science Translational Medicine.
Tan said the research team -- which also included scientists from the National University of Singapore, National Cancer Centre of Singapore, the Genome Institute of Singapore, Yonsei University College of Medicine in Seoul, South Korea, and Howard University -- used a novel genomic approach to isolate the fusion gene.
The technology is called genomic breakpoint analysis (GBA), which has been used to identify fusion genes in leukemia, but has had less success in pinpointing them in complex solid tumors.
By using the technology to home in on abnormal genes in 133 stomach cancer tumors and cell lines, the Singapore-based research group found evidence of a single genetic error that was common to four of the cancer samples.
Finding the error led the scientists to the CD44-SLC1A2 fusion gene, which resulted when two nearby genes blended into one. The SLC1A2 gene is associated with the metabolism of the amino acid glutamate, which can work like a fertilizer encouraging tumor growth and survival, while the CD44 gene serves as a sort of "on" switch.
Melded into one, the CD44-SLC1A2 hybrid appears to fuel stomach tumors. Tan's team estimates the fusion gene may be at work in up to 2 percent of stomach cancers.
"Using high-throughput genomic technologies such as sequencing and GBA, we are now finding that cancers do express many fusion genes," Tan said. "The current feeling is that while most of these are harmless and 'noise' from genomic instability, there can be cases, such as CD44-SLC1A2, where the fusion gene contributes actively to the cancer."
The finding could lead to improved therapies for this subset of stomach cancers. As part of the study, the researchers used a gene silencing approach to reduce the levels of CD44-SLC1A2 in cancer cell lines. They found that this caused a reduction in the glutamate levels of cancer cells, and made the cells more vulnerable to the effects of cisplatin, a common chemotherapy.
"It does suggest that drugs that inhibit SLC1A2 function could be used to sensitize tumors to chemotherapy," Tan said. "Such glutamate uptake inhibitors are available, and we are working very hard to test this possibility."
###
In addition to Tan, study authors included:
Jiong Tao, Baohua Huang and Celestial Yap of the National University of Singapore; Nian Tao Deng, Chia Huey Ooi, Iain Beehuat Tan and Shenli Zhang of the Duke-NUS Graduate Medical School; Kalpana Ramnarayanan, Hue Kian Oh, Jeanie Wu, Minghui Lee, Siew Hong Leong and Oi Lian Kon of the National Cancer Centre of Singapore;
Seong Soo Lim, Valere Cacheux and Nallasivam Palanisamy of the Genome Institute of Singapore; Sun Young Rha and Hyun Cheol Chung of the Yonsei University College of Medicine; Duane T. Smoot and Hassan Ashktorab of Howard University College of Medicine.
The study was funded by the Biomedical Research Council and National Medical Research Council of Singapore, Duke-NUS Graduate Medical School Singapore, and the Cancer Sciences Institute of Singapore.
END
Pacific Eye (www.paceyemd.com), the premier ophthalmology practice that provides optometry services in San Luis Obispo and Santa Barbara counties, continues to support the communities it serves with its sponsorship of the SLO Symphony's 50th anniversary season.
Pacific Eye is known for providing comprehensive vision care services, including routine eye care, cataract surgery, and refractive surgical procedures including IntraLase LASIK in San Luis Obispo. In addition to their professional services, the practice is devoted to supporting their community. For example, ...
Advance announces its new website with an enhanced structural design and efficient navigation tools for improved product selection and comprehensive service information. Providing a clean layout, the new website allows users to quickly access product information--including service manuals and parts list--by browsing various product categories or searching within multiple vertical markets.
Featuring a simple navigation bar, users can easily locate Advance products or learn about Advance's comprehensive cleaning solutions, including its innovative EcoFlex System cleaning ...
MediaBoss Television, a broadcast media, full creative, audio and video production company, announced today their expansion to a six thousand square foot facility in Framingham, Mass.
MediaBoss Television provides the best digital content, creative services video and audio production to a variety of companies in the area like IBM, VGo Communications and Ipswitch, Inc. MediaBoss Television also produces local entertainment show, "Track Gals," which airs both on Boston CBS affiliate Channel 4 as well as WSBK's TV38.
"The expansion of MediaBoss is a large step in achieving ...
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.
The findings, published online in the journal Nature, expand the possibility of creating biomarkers that can better diagnose those with mental illnesses and track their treatment.
Building on previous studies at Hopkins, the new research further offers clues to why the Disrupted In Schizophrenia gene (DISC1) and its protein product plays so many distinct ...
DURHAM, N.C. – An international team of scientists lead by researchers from Duke University and Johns Hopkins University have discovered a key "switch" in the brain that allows neurons to stop dividing so that these cells can migrate toward their final destinations in the brain.
The finding may be relevant to making early identification of people who go on to develop schizophrenia and other brain disorders.
"This work sheds light on what has been a big black box in neuroscience," said Nicholas Katsanis, Ph.D., co-senior author of the work and Jean and George Brumley ...
PHILADELPHIA (April 6, 2011) – Following years of futile attempts, new research from the Monell Center demonstrates that living human taste cells can be maintained in culture for at least seven months. The findings provide scientists with a valuable tool to learn about the human sense of taste and how it functions in health and disease.
This advance ultimately will assist efforts to prevent and treat taste loss or impairment due to infection, radiation, chemotherapy and chemical exposures.
"People who undergo chemotherapy or radiation therapy for oral cancer often ...
Boston, MA - A new 17 year follow-up study of 37,000 Israeli teenagers found that diabetes risk is mainly associated with increased body mass index (BMI) close to the time of diagnosis at early adulthood, while coronary heart disease risk is associated with elevated BMI both at adolescence and adulthood. The findings are published in the April 7 issue of the New England Journal of Medicine.
Lead study author, Amir Tirosh, MD PhD, of the Endocrine Division at Brigham and Women's Hospital said, "The study suggests that the obesity problem in children and teens is likely ...
A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women.
The women in the study had a short cervix, which is known to increase the risk for preterm birth. The cervix is the part of the uterus that opens and shortens during labor.
The study also found that infants born to women who had received progesterone were less likely to develop respiratory distress syndrome, a breathing complication occurring in preterm ...
New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin.
Insulin secretagogues (ISs), such as glimepiride, glibenclamide (known as glyburide in the USA and Canada), gliclazide and tolbutamide, have been used to treat type 2 diabetes since the 1950-1970s, Nevertheless, the long-term risk associated with these drugs has largely been unknown. Metformin is the first drug of choice in type 2 diabetes, ...
International Women in Jazz Festival 2011, featuring The Antoinette Montague Group with Tammy Hall, Bill Easley and Payton Crossley. Held at Saint Peter's Church, 54th Street at Lexington Ave, NYC, on Saturday, April 9, 2011 from 12:30pm to 9:30pm.
International Women in Jazz Festival 2011 schedule:
12:30 - 2:00 pm Masterclass by Melba Joyce
2:15 - 3:15 pm Jam session: Linda Presgrave Trio
4:15 - 5:30 pm IWJ honorees:
Paul Ash, Sam Ash Music Corporation
Rhonda Hamilton, WBGO
Remembering Trudy Pitts by Mr. C
Sally Placksin, Moderator
5:45 - 6:45 pm Reception: ...
